Ewing Weight Loss Clinic

Ewing Weight Loss Clinic has served Reno, Nevada since 1998, providing physician-supervised weight management programs under the direction of Robert K. Ewing II, DO. With over two decades of clinical experience in medical weight loss, Dr. Ewing combines osteopathic principles with evidence-based pharmacotherapy to address obesity and metabolic dysfunction. The clinic's longevity in the Reno community reflects a sustained commitment to individualized care, with programs designed around each patient's metabolic profile, lifestyle constraints, and weight loss objectives rather than one-size-fits-all protocols.

The clinic offers a comprehensive range of GLP-1 receptor agonists and dual-incretin therapies, including Semaglutide, Tirzepatide, Retatrutide, and Liraglutide. Semaglutide is prescribed for patients seeking appetite regulation and improved glycemic control, while Tirzepatide—a dual GIP/GLP-1 receptor agonist—is utilized for patients who may benefit from enhanced insulin sensitivity and greater weight reduction potential. Retatrutide, a triple-incretin receptor agonist targeting GLP-1, GIP, and glucagon pathways, represents the clinic's access to emerging pharmacologic options for patients with significant weight loss goals or those who have plateaued on single-agent therapy. Liraglutide remains a foundational option for patients requiring once-daily dosing or those transitioning from other metabolic therapies. Each peptide is prescribed following comprehensive metabolic assessment, with dosing protocols adjusted based on patient response, tolerability, and clinical markers.

Dr. Ewing's osteopathic training informs a whole-person approach that extends beyond peptide prescribing to include nutritional counseling, metabolic optimization, and hormone replacement therapy when indicated. Patients undergo initial consultations that assess thyroid function, sex hormone status, insulin resistance markers, and body composition analysis to identify underlying factors contributing to weight gain or metabolic stagnation. The clinic's bariatric programs integrate dietary protein targets, meal timing strategies, and behavioral modification techniques alongside pharmacotherapy. Hormone replacement therapy is available for patients whose weight loss efforts are complicated by perimenopause, menopause, andropause, or thyroid dysfunction, addressing the hormonal contributors to metabolic slowdown and fat accumulation that often undermine conventional diet-and-exercise approaches.

Patients at Ewing Weight Loss Clinic receive in-person consultations at the Reno office, allowing for direct physical assessment, body composition measurement, and face-to-face discussion of treatment goals and expectations. Follow-up visits are scheduled to monitor peptide response, adjust dosing, review dietary adherence, and address side effects such as nausea or gastrointestinal changes common in early GLP-1 therapy. The clinic provides clear guidance on protein intake requirements during active weight loss to preserve lean muscle mass, a critical factor in maintaining metabolic rate and preventing weight regain. Patients are educated on realistic timelines, with emphasis on sustainable fat loss rather than rapid but unsustainable results, and are supported through weight plateaus with protocol adjustments or peptide transitions as clinically appropriate.

With a 4.9-star rating across 38 Google reviews, the clinic has built a reputation in the Reno area for accessible, results-oriented care. The practice's quarter-century presence in Nevada's medical weight loss landscape demonstrates both clinical stability and adaptability to evolving treatment modalities, from early appetite suppressants to today's incretin-based therapies. Dr. Ewing's willingness to incorporate newer agents like Retatrutide while maintaining foundational approaches reflects a balanced, evidence-informed practice philosophy that prioritizes patient outcomes over treatment trends.